Pharma: Other news to note
Tuesday, February 18, 2014
Mayne Pharma USA, of Greenville, N.C., has agreed to acquire the headache drugs Esgic (butalbital, acetaminophen, and caffeine) and Esgic Plus (butalbital, acetaminophen, and caffeine), as well as Lorcet (hydrocodone bitartrate and acetaminophen) and Lorcet Plus brands, for pain, and related assets from Forest Laboratories Inc., of New York, for $12 million.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.